CopyFind
ДЖІСІ ФЛЮ/GC FLU ВАКЦИНА ДЛЯ ПРОФІЛАКТИКИ ГРИПУ (РОЗЩЕПЛЕНИЙ ВІРІОН, ІНАКТИВОВАНИЙ)
medicine 📍 UA

ДЖІСІ ФЛЮ/GC FLU ВАКЦИНА ДЛЯ ПРОФІЛАКТИКИ ГРИПУ (РОЗЩЕПЛЕНИЙ ВІРІОН, ІНАКТИВОВАНИЙ)

Analogs of ДЖІСІ ФЛЮ/GC FLU ВАКЦИНА ДЛЯ ПРОФІЛАКТИКИ ГРИПУ (РОЗЩЕПЛЕНИЙ ВІРІОН, ІНАКТИВОВАНИЙ)

Find cheaper analogs and generic equivalents for ДЖІСІ ФЛЮ/GC FLU ВАКЦИНА ДЛЯ ПРОФІЛАКТИКИ ГРИПУ (РОЗЩЕПЛЕНИЙ ВІРІОН, ІНАКТИВОВАНИЙ).

Ingredients

Active Ingredient: Influenza, inactivated, split virus or surface antigen


Product Overview

About ДЖІСІ ФЛЮ/GC FLU ВАКЦИНА ДЛЯ ПРОФІЛАКТИКИ ГРИПУ (РОЗЩЕПЛЕНИЙ ВІРІОН, ІНАКТИВОВАНИЙ)

ДЖІСІ ФЛЮ/GC FLU ВАКЦИНА ДЛЯ ПРОФІЛАКТИКИ ГРИПУ (РОЗЩЕПЛЕНИЙ ВІРІОН, ІНАКТИВОВАНИЙ) is a vaccine designed to provide protection against influenza, commonly known as the flu. It contains the active ingredient Influenza, inactivated, split virus or surface antigen, which helps the body's immune system to recognize and fight the flu virus.

Key Benefits & Uses

  • Prevents influenza, reducing the risk of complications and hospitalization
  • Helps to reduce the spread of the flu virus in the community
  • Provides immunity against specific strains of the flu virus, as indicated by the World Health Organization

Active Ingredient & Action

The active ingredient Influenza, inactivated, split virus or surface antigen in ДЖІСІ ФЛЮ/GC FLU ВАКЦИНА ДЛЯ ПРОФІЛАКТИКИ ГРИПУ (РОЗЩЕПЛЕНИЙ ВІРІОН, ІНАКТИВОВАНИЙ) works by stimulating the body's immune system to produce antibodies that recognize and fight the flu virus. This helps to prevent infection and reduce the severity of symptoms if infection occurs.

Important Notes

It is essential to follow the recommended dosage and administration schedule for ДЖІСІ ФЛЮ/GC FLU ВАКЦИНА ДЛЯ ПРОФІЛАКТИКИ ГРИПУ (РОЗЩЕПЛЕНИЙ ВІРІОН, ІНАКТИВОВАНИЙ) to ensure optimal protection against the flu. As with any vaccine, there may be side effects, and individuals should consult their healthcare provider if they have any concerns or questions.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.

Similar Products & Analogs

IDflu

Active: influenza virus (inactivated, split) of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain (A/California/7/2009, NYMC X-179A)A/Hong Kong/4801/2014 (H3N2) - like strain (A/Hong Kong/4801/2014, NYMC X-263B)B/Brisbane/60/2008 - like strain (B/Brisbane/60/2008, wild type)

Match: 60% Compare →
Fluenz

Active: reassortant influenza virus (live attenuated) of the following strains:A/California/7/2009 (H1N1)pdm09 like strain, A/Victoria/361/2011 (H3N2) like strain, B/Massachusetts/2/2012 like strain

Match: 60% Compare →
Hexyon

Active: filamentous haemagglutinin;Haemophilus influenzae type B polysaccharide (polyribosylribitol phosphate);hepatitis B surface antigen;pertussis toxoid;poliovirus (inactivated) type 1 (Mahoney strain) produced on Vero cells;poliovirus (inactivated) type 2 (MEF-1 strain) produced on Vero cells;poliovirus (inactivated) type 3 (Saukett strain) produced on Vero cells;tetanus protein;tetanus toxoid adsorbed on aluminium hydroxide, hydrated;Diphtheria toxoid

Match: 60% Compare →
ACT-HIB

Active: TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B-PRP

Match: 60% Compare →
FLUMIST

Active: INFLUENZA VIRUS TYPE A (H1N1), INFLUENZA VIRUS TYPE A (H3N2), INFLUENZA VIRUS TYPE B

Match: 60% Compare →
Vaxelis

Active: Diphtheria toxoid;tetanus toxoid;Bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae Types 2 and 3;hepatitis B surface antigen produced in yeast cells;poliovirus (inactivated): type 1 (Mahoney), type 2 (MEF-1), type 3 (Saukett) produced in Vero cells/ Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to meningococcal protein

Match: 60% Compare →
Vepacel

Active: Influenza virus (whole virion, inactivated), containing antigen of: A/Vietnam/1203/2004 (H5N1)

Match: 60% Compare →
Intanza

Active: influenza virus (inactivated, split) of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain (A/California/7/2009, NYMC X-179A)A/Hong Kong/4801/2014 (H3N2) - like strain (A/Hong Kong/4801/2014, NYMC X-263B)B/Brisbane/60/2008 - like strain (B/Brisbane/60/2008, wild type)

Match: 60% Compare →
Optaflu

Active: influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain(A/Brisbane/10/2010, wild type)A/Switzerland/9715293/2013 (H3N2) - like strain(A/South Australia/55/2014, wild type)B/Phuket/3073/2013�like strain(B/Utah/9/2014, wild type)

Match: 60% Compare →
Pumarix

Active: pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)�

Match: 60% Compare →
Hexavac

Active: purified diphtheria toxoid;purified tetanus toxoid;purified pertussis toxoid;purified pertussis filamentous haemagglutinin;hepatitis B surface antigen;Inactivated Type 1 Poliovirus (Mahoney);Inactivated Type 3 Poliovirus (Saukett);Haemophilus influenzae type b polysaccharide

Match: 60% Compare →
Humenza

Active: split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs

Match: 60% Compare →